Aeterna Zentaris
AEZS
$2.65
Share price
0.76%
Change (1 day)
-69.71%
Change (1 year)
Categories
EPS for Aeterna Zentaris (AEZS)
EPS in 2022 (TTM): -$2.32
According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -$2.32. In 2021 the company made an earnings per share (EPS) of -$1.75 an increase over its 2020 EPS that were of -$3.00.
EPS history for Aeterna Zentaris from 2001 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$2.32 | 32.57% |
| 2021 | -$1.75 | -41.67% |
| 2020 | -$3.00 | -65.71% |
| 2019 | -$8.75 | -240% |
| 2018 | $6.25 | -122.32% |
| 2017 | -$28.00 | -53.53% |
| 2016 | -$60.25 | -86.71% |
| 2015 | -$453.50 | -35.21% |
| 2014 | -$700.00 | -216.67% |
| 2013 | $600.00 | -123.3% |
| 2012 | -$2,575 | -40.8% |
| 2011 | -$4,350 | -6.45% |
| 2010 | -$4,650 | -27.91% |
| 2009 | -$6,450 | -61.61% |
| 2008 | -$16,800 | 83.61% |
| 2007 | -$9,150 | -195.31% |
| 2006 | $9,600 | 178.26% |
| 2005 | $3,450 | -312.69% |
| 2004 | -$1,622 | -78.43% |
| 2003 | -$7,519 | 17.78% |
| 2002 | -$6,384 | 515.93% |
| 2001 | -$1,036 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $9.79 | -521.98% | 🇨🇭 Switzerland |
 Sanofi SNY | $3.30 | -242.12% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $3.12 | -234.56% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -$0.64 | -72.41% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.48 | -163.79% | 🇺🇸 USA |